Adient
ADNT | NYSE
$17.66
+$0.97 (+5.81%)
Nov 2, 2026, 12:15 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Sep 30, 2025 | FY 2024 Sep 30, 2024 | FY 2023 Sep 30, 2023 | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 | FY 2020 Sep 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 14.54B | 14.69B | 15.4B | 14.12B | 13.68B | 12.67B |
Cost of Revenue | 13.57B | 13.76B | 14.36B | 13.31B | 12.85B | 12.08B |
Gross Profit | 961M | 928M | 1.03B | 807M | 826M | 592M |
Operating Income | 439M | 421M | 479M | 209M | 289M | 42M |
Interest Income | 24M | 10M | 22M | 9M | 7M | 11M |
Pretax Income | -88M | 133M | 295M | 54M | 1.44B | -429M |
Net Income | -281M | 18M | 205M | -120M | 1.11B | -486M |
Selling & General & Admin | 522M | 507M | 554M | 598M | 537M | 572M |
Research & Development | 387M | 372M | 362M | 322M | 316M | 370M |
Other Expenses | -387M | -372M | -362M | -322M | -316M | -370M |
Operating Expenses | 522M | 507M | 554M | 598M | 537M | 572M |
Interest Expense | 205M | 191M | 203M | 188M | 258M | 235M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 558M |
Cost & Expenses | 14.1B | 14.27B | 14.92B | 13.91B | 13.39B | 12.65B |
Income Tax Expense | 103M | 32M | n/a | 94M | 249M | 57M |
Shares Outstanding (Basic) | 83M | 89.5M | 94.5M | 94.8M | 94.2M | 93.8M |
Shares Outstanding (Diluted) | 83M | 90.1M | 95.4M | 94.8M | 95.7M | 93.8M |
EPS (Basic) | -3.39 | 0.20 | 2.17 | -1.27 | 11.76 | -5.18 |
EPS (Diluted) | -3.39 | 0.20 | 2.15 | -1.27 | 11.58 | -5.18 |
EBITDA | 438M | 656M | 828M | 603M | 2.03B | 119M |
EBIT | 113M | 324M | 488M | 253M | 1.7B | -1M |
Depreciation & Amortization | 325M | 332M | 340M | 350M | 330M | 332M |
Add to Watchlist
Select watchlists to add or remove ADNT